Market revenue in 2023 | USD 71.1 million |
Market revenue in 2030 | USD 119.9 million |
Growth rate | 7.8% (CAGR from 2023 to 2030) |
Largest segment | Project and data management |
Fastest growing segment | System and Technology Support Services |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Clinical Trial Design and Consultation Services, Reading and Analytical Services, Operational Imaging Services, System and Technology Support Services, Project and Data Management |
Key market players worldwide | Ixico, Navitas Organics, Medpace Holdings Inc, Clario, BioTelemetry, ProScan Imaging, Cardiovascular Imaging Technologies, Intrinsic Imaging, Resonance Health |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial imaging market will help companies and investors design strategic landscapes.
Project and data management was the largest segment with a revenue share of 28.69% in 2023. Horizon Databook has segmented the Latin America clinical trial imaging market based on clinical trial design and consultation services, reading and analytical services, operational imaging services, system and technology support services, project and data management covering the revenue growth of each sub-segment from 2018 to 2030.
Clinical research is increasing in Latin America and other emerging nations mainly due to cost effectiveness, presence of regulatory agencies for research, and good capability of patient recruitment & enrollment, and presence of developing economies in the region, which is boosting research capacity.
In addition, with increasing urbanization, the incidence of lifestyle-related diseases such as obesity, cardiovascular diseases, and diabetes is increasing.
Thus, Latin America is beginning to reflect the disease pattern similar to the U.S. and European countries. Hence, the number of clinical trials is expected to increase, thereby driving the market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America clinical trial imaging market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America clinical trial imaging market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account